← Leaderboards
Krishna Rajarathnam
University Of Texas Medical Br Galveston
$6,979,683
Attributed
$7,229,151
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $788.6K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,229,151 · 8
By mechanism
P01$2,933,217 · 1
R21$2,238,080 · 5
R01$1,937,504 · 1
S10$120,350 · 1
Top collaborators
- Ashok K Chopra3 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- James C Lee$2,472,297
- Ashok K Chopra$11,194,492
- Frank C. Schmalstieg$996,636
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignMediatingChemokineMolecularPlayNeutrophil InfiltrationStructureMonomerDimerNeutrophilInflammatoryBaseRecruitment ActivityIn VivoAffinityPropertyCoupledAnimalsAnimal ModelDimerizationInflammationPreventIl8 GeneGlycosaminoglycans
Grant awards (25)
Structural Basis of chemokine CXCL1 recognition with CXCR2 receptor$200,000
R21 · FY2022 · AI · contact PI
Structural Basis of chemokine CXCL1 recognition with CXCR2 receptor$252,914
R21 · FY2021 · AI · contact PI
Engineered chemokines as therapeutics for bacterial infections$197,500
R21 · FY2019 · AI · contact PI
Engineered chemokines as therapeutics for bacterial infections$65,436
R21 · FY2019 · AI · contact PI
Engineered chemokines as therapeutics for bacterial infections$236,000
R21 · FY2018 · AI · contact PI
Heparan Sulfate - Chemokine Interactions and Inflammation$370,130
P01 · FY2017 · HL · contact PI
Chemokine Synergy and Neutrophil Function$193,750
R21 · FY2017 · AI · contact PI
Malvern MicroCal PEAQ Isothermal Titration Calorimeter$120,350
S10 · FY2017 · OD · contact PI
Heparan Sulfate - Chemokine Interactions and Inflammation$410,175
P01 · FY2016 · HL · contact PI
Chemokine Synergy and Neutrophil Function$232,500
R21 · FY2016 · AI · contact PI
Heparan Sulfate - Chemokine Interactions and Inflammation$418,340
P01 · FY2015 · HL · contact PI
Heparan Sulfate - Chemokine Interactions and Inflammation$411,812
P01 · FY2014 · HL · contact PI
Heparan Sulfate - Chemokine Interactions and Inflammation$410,183
P01 · FY2013 · HL · contact PI
Chemokine CXCL17 and Mucosal Immunosurveillance$215,730
R21 · FY2013 · AI · contact PI
Heparan Sulfate - Chemokine Interactions and Inflammation$441,202
P01 · FY2012 · HL · contact PI
Chemokine CXCL17 and Mucosal Immunosurveillance$191,250
R21 · FY2012 · AI · contact PI
Heparan Sulfate - Chemokine Interactions and Inflammation$471,375
P01 · FY2011 · HL · contact PI
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation$317,189
R01 · FY2011 · AI · contact PI
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation$320,393
R01 · FY2010 · AI · contact PI
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation$323,629
R01 · FY2009 · AI · contact PI
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation$323,629
R01 · FY2008 · AI · contact PI
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation$329,897
R01 · FY2007 · AI · contact PI
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammation$322,767
R01 · FY2006 · AI · contact PI
Characterization of CCR5 Receptor N-terminal domain$226,500
R21 · FY2005 · AI
Characterization of CCR5 Receptor N-terminal domain$226,500
R21 · FY2004 · AI